Centre National de la Recherche Scientifique (CNRS);Universite de Montpellier;University of Parma;Ecole Nationale Superieure de Chimie
发明人:
Gerard Cros,Alan Crozier,Margherita Dall'asta,Daniele Del Rio,Richard Magous,Catherine Oiry
申请号：
US16751677
公开号：
US20200155504A1
申请日:
2020.01.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes.
